Biotech Showcase
Save the date!
Biotech Showcase 2023January 9–11, 2023

Andrew Meadow
General Partner at Health Innovation Capital

Profile

Education

MA studies, Healthcare Economics
Rotterdam School of Management

MBA, Healthcare Finance and Strategy
Case Western Reserve University
Weatherhead Scholar


BA with Honors
Franklin and Marshall College

Venture Capital Experience

  • Over 27 years experience in healthcare venture capital with three healthcare and life science funds: Essex Woodlands, the Michigan Economic Development Corp’s Healthcare Fund, and Excelyrate Capital

    • Career 3.8x Net Cash-on-Cash Return as a principal investor

    • 12 Investments and 9 Exits to date

    • Evaluated and due diligence of over 1,500 companies

  • As an investment banker at UBS Warburg, executed nearly 20 biotech and MedTech transactions, with over $20B in IPO, M&A, and equity/debt financings over his career

Pharmaceutical Experience

  • Business development, investment/acquisition diligence and commercial strategy executive experience in both large cap pharma and rapid growth start-up stage biotech and MedTech companies including: 

    • Baxter Corp.  (Manager, Corp. Development & M&A)

    • SkinAxis (SVP, Commercial Operations and Strategy)

    • Conceivex, Inc. (Chief Strategy and Business Development Officer) 

  • Responsible for leading and executing the commercialization and alliance management strategy for three (3) products, each achieving between $85 to $174M in Gross Revenue within 18 months respectively

  • As a C-Suite executive, Andrew has successfully led three healthcare companies to successful M&A exits

Agenda Sessions

  • COVID: What to Expect Next

    14:00

Speakers at this event